Skip to content
Axcess News – Lifestyle
Author:
NAVER CORPORATION
Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement
August 20, 2026
NAVER D2SF Invests in Clone Labs, an AI Startup That Predicts User Intent and Decisions
May 18, 2026
NAVER D2SF Makes Follow-On Investment in Soundable Health, an AI-Driven Health Tech Startup Scaling in the U.S. Market
March 30, 2026
NAVER D2SF Makes Follow-On Investment in Nuvilab, AI Nutrition Analytics Startup
March 30, 2026
NAVER D2SF Invests in Anyware Robotics, a Physical AI Startup Starting from Logistics Automation
March 10, 2026
NAVER D2SF Invests in Physical AI Startup ‘Khameleon’
March 9, 2026